title: Neuroendocrine findings in anxiety disorders.
abstract: Anxiety disorders are newly defined syndromes in which inappropriate state anxiety is the sole or primary symptom. Hormonal manifestations of acute stress are usually minimal or absent in these disorders. A number of findings suggest receptor downregulation or enzyme induction of sorts that would be expected to mute or dampen these responses.
authors.affiliation: University of Michigan, School of Medicine, Ann Arbor.
authors.forename: G C
authors.initials: GC
authors.lastname: Curtis
authors.forename: D A
authors.initials: DA
authors.lastname: Glitz
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D001008:Anxiety Disorders / Q000097:blood* / Q000145:classification; D002395:Catecholamines / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008734:Methoxyhydroxyphenylglycol / Q000097:blood; D009490:Neurosecretory Systems / Q000378:metabolism / Q000503:physiopathology*; D009771:Obsessive-Compulsive Disorder / Q000097:blood; D013315:Stress, Psychological / Q000097:blood
chemical_list: D002395:Catecholamines; D008734:Methoxyhydroxyphenylglycol; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D006854:Hydrocortisone